NCT05870748 · Interventional trial
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
Overall registry status Terminated
Phase 2 · Phase 3
Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer
Delaware Valley sites
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory